Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Exclusion Criteria

• •1. Previously received radiation therapy for the head and neck area;
• •2. Differentiated thyroid cancer with poorly differentiated, or undifferentiated components;
• •3. There is distant metastasis;
• •4. Previously received 131I treatment;
• •5. Previously received or currently receiving targeted therapy, immunotherapy, chemotherapy;
• •6. Within 5 years or simultaneously suffering from other active malignant tumors. Cured local tumors, such as skin basal cell carcinoma, skin squamous cell carcinoma, superficial bladder cancer, prostate carcinoma in situ, cervical carcinoma in situ, breast carcinoma in situ, can be included in the group;
• •7. Pregnant or lactating women;
• •8. Other physical illnesses that affect patients' ability to receive standard treatment;
• •9. According to the researchers' assessment, there may be other factors that could force the subjects to terminate the study, such as suffering from other serious illnesses (including mental illnesses) that require concurrent treatment, severe abnormal laboratory test values, family or social factors that may affect the safety of the subjects or the collection of experimental data;
• •10. Individuals with claustrophobia who are unable to undergo radiation therapy;
• •11. Patients deemed unsuitable for inclusion by other attending physicians.